Proton Pump Inhibitors Linked To Liver Disease
Researchers have linked proton pump inhibitors (PPIs) to liver disease. PPIs make changes to gut bacteria that promote liver disease in existing patients.
Researchers have linked proton pump inhibitors (PPIs) to liver disease. PPIs make changes to gut bacteria that promote liver disease in existing patients.
The Mediterranean diet and drinking alkaline water are shown to be better at treating acid reflux symptoms than PPIs. Consider diet as an option for treating reflux.
Taking heartburn medication improperly reduces its effectiveness. Increase the effectiveness of H2 blockers by taking the drug with an 8oz glass of water.
PPIs, a heartburn drug used by millions, are linked to a higher risk of death. Increased mortality rates are likely associated with PPI side effects.
Chronic kidney disease (CKD) is now linked to use of certain heartburn medications. PPI users are at greater risk of chronic kidney disease and should know the dangers.
How to wean off PPIs without acid rebound. Improve your health and avoid the adverse side effects of long-term PPI use. Wean off PPIs by gradually reducing dosage by 25%-50% each week until your at 25%-50% of current intake. Tapering at 50% will take one week. Tapering by 25% will take 3 weeks. The slower the weaning process the less likelihood of acid rebound.
A proton pump inhibitor (PPI) is a drug used to reduce the production of stomach acid giving the esophagus, stomach, and duodenum (first part of the intestines) time to heal from irritation and erosive damage. The decrease in acid production will also help reduce acid reflux related heartburn.
There are 3 levels of OTC medications for treating heartburn and acid reflux: antacids, histamine receptor blockers (H2 blockers), and Proton Pump Inhibitors (PPI’s).